News from Friday, January 24, 2025
Articles
Podcast: Why Healthcare Needs a Patient-Centered Approach to AI Use
(1/24, Kelsey Waddill, TechTarget) reports “...In this episode, Prashila Dullabh, the vice president and senior fellow in the department of health sciences at NORC at the University of Chicago, sat down with Healthcare Strategies to discuss the opportunities and pitfalls of AI-powered clinical decision-making and what stakeholders can do to make the most of these tools.” Full
As Another Trump Term Gets Underway, Pharma Advisors Get Comfortable With Uncertainty
(1/23, Max Bayer, Endpoints News) reports “...The reality of a Trump administration is that it's a ‘fluid dynamic,’ said Stephen Ubl, CEO of the trade group PhRMA...On the IRA, Ubl is ‘cautiously optimistic’ that persistent lobbying against specific elements of the bill could be changed. Namely, PhRMA is hoping to reverse what it’s dubbed the ‘pill penalty,’ a provision that makes oral drugs subject to price negotiations earlier than biologics. ‘There isn’t anyone that I’ve met that has put forward a credible argument for why there should be a disparity in how these drugs are treated under the law,’ Ubl said.” Subscription Required
Journals
A Systematic Review of Outcomes Reported in Studies to Optimise the Medication Use of Patients at Hospital Discharge
Joke Wuyts, et al.
January 24, 2025, BMC Health Services Research
Comparative Effectiveness of Antipsychotic Treatment Strategies for Relapse Prevention in First-Episode Schizophrenia in Finland: A Population-Based Cohort Study
Heidi Taipale, et al.
February 2025, The Lancet Psychiatry